| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |